symbravo

Generic: meloxicam, rizatriptan

Labeler: axsome therapeutics, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name symbravo
Generic Name meloxicam, rizatriptan
Labeler axsome therapeutics, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

meloxicam 20 mg/1, rizatriptan benzoate 10 mg/1

Manufacturer
Axsome Therapeutics, Inc.

Identifiers & Regulatory

Product NDC 81968-020
Product ID 81968-020_b625951b-f029-470d-8d35-f5b6a92a06bb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215431
Listing Expiration 2026-12-31
Marketing Start 2025-05-19

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 81968020
Hyphenated Format 81968-020

Supplemental Identifiers

RxCUI
2711789 2711795
UPC
0381968020034 0381968020096
UNII
VG2QF83CGL WR978S7QHH
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name symbravo (source: ndc)
Generic Name meloxicam, rizatriptan (source: ndc)
Application Number NDA215431 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (81968-020-02) / 2 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (81968-020-03) / 3 TABLET in 1 BOTTLE
  • 9 TABLET in 1 BOTTLE (81968-020-09)
source: ndc

Packages (3)

81968-020-02 1 BOTTLE in 1 CARTON (81968-020-02) / 2 TABLET in 1 BOTTLE 81968-020-03 1 BOTTLE in 1 CARTON (81968-020-03) / 3 TABLET in 1 BOTTLE 81968-020-09 9 TABLET in 1 BOTTLE (81968-020-09)

Ingredients (2)

meloxicam (20 mg/1) rizatriptan benzoate (10 mg/1)

Linked Drug Pages (1)

SYMBRAVO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b625951b-f029-470d-8d35-f5b6a92a06bb", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0381968020034", "0381968020096"], "unii": ["VG2QF83CGL", "WR978S7QHH"], "rxcui": ["2711789", "2711795"], "spl_set_id": ["dcf1ecd1-08a0-8e47-e053-2a95a90abdc7"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Axsome Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 BOTTLE in 1 CARTON (81968-020-02)  / 2 TABLET in 1 BOTTLE", "package_ndc": "81968-020-02", "marketing_start_date": "20251121"}, {"sample": true, "description": "1 BOTTLE in 1 CARTON (81968-020-03)  / 3 TABLET in 1 BOTTLE", "package_ndc": "81968-020-03", "marketing_start_date": "20250519"}, {"sample": false, "description": "9 TABLET in 1 BOTTLE (81968-020-09)", "package_ndc": "81968-020-09", "marketing_start_date": "20250519"}], "brand_name": "SYMBRAVO", "product_id": "81968-020_b625951b-f029-470d-8d35-f5b6a92a06bb", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Serotonin 1b Receptor Agonists [MoA]", "Serotonin 1d Receptor Agonists [MoA]", "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"], "product_ndc": "81968-020", "generic_name": "meloxicam, rizatriptan", "labeler_name": "Axsome Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SYMBRAVO", "active_ingredients": [{"name": "MELOXICAM", "strength": "20 mg/1"}, {"name": "RIZATRIPTAN BENZOATE", "strength": "10 mg/1"}], "application_number": "NDA215431", "marketing_category": "NDA", "marketing_start_date": "20250519", "listing_expiration_date": "20261231"}